Updated review of prevalence of major risk factors and use of screening tests for cancer in the United States

Cancer Epidemiology Biomarkers and Prevention

Volumn 26, Issue 8, 2017, Pages 1192-1208

  Sauer, Ann Goding ^a   Siegel, Rebecca L ^a   Jemal, Ahmedin ^a   Fedewa, Stacey A ^a  

^a AMERICAN CANCER SOCIETY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL;

ALCOHOLIC BEVERAGE; BREAST CANCER; CANCER IMMUNIZATION; CANCER SCREENING; COLORECTAL CANCER; DIET; EDUCATIONAL STATUS; FOOD INTAKE; FRUIT; HELICOBACTER PYLORI; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; LUNG CANCER; NUTRITION; OBESITY; PAPANICOLAOU TEST; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PROCESSED MEAT; PROSTATE CANCER; RADIATION EXPOSURE; RED MEAT; REVIEW; SKIN CANCER; SKIN PROTECTION; SMOKING; SMOKING CESSATION; SOCIAL STATUS; TOBACCO USE; ULTRAVIOLET RADIATION; UNITED STATES; UTERINE CERVIX CANCER; VEGETABLE; WART VIRUS; WHOLE GRAIN; ADOLESCENT; ADULT; CHILD; EARLY CANCER DIAGNOSIS; FEMALE; MALE; NEOPLASM; PATHOLOGY; PRESCHOOL CHILD; PREVALENCE; RISK FACTOR; YOUNG ADULT;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; EARLY DETECTION OF CANCER; FEMALE; HUMANS; MALE; NEOPLASMS; PREVALENCE; RISK FACTORS; YOUNG ADULT;

EID: 85026824480     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-17-0219     Document Type: Review

References (143)

1. US Department of Health and Human Services. Smoking and Health Report of the Advisory Committee to the Surgeon General of the Public Health Service. Washington, DC: Public Health Service; 1964.
2. Doll R, Peto R. The causes of cancer. New York, NY: Oxford Press; 1981.
3. World Cancer Research Fund and American Institute for Cancer Research. Continuous Update Project World Cancer Research Fund and American Institute for Cancer Research. Available from: http://www.wcrf.org/int/research-we-fund/continuous-update-project-cup.
4. Siegel RL, Miller KD, Jemal A. Cancer Statistics, 2017. CA Cancer J Clin 2017;67:7-30.
5. Jacobs EJ, Newton CC, Carter BD, Feskanich D, Freedman ND, Prentice RL, et al. What proportion of cancer deaths in the contemporary United States is attributable to cigarette smoking? Ann Epidemiol 2015;25: 179-82.
6. Fedewa SA, Sauer AG, Siegel RL, Jemal A. Prevalence of major risk factors and use of screening tests for cancer in the United States. Cancer Epidemiol Biomarkers Prev 2015;24:637-52.
7. National Center for Health Statistics. National Health Interview Survey. Public-use data file and documentation; 2015. Available from: http://www.cdc.gov/nchs/nhis/quest-data-related-1997-forward.htm.
8. Centers for Disease Control and Prevention. Behavioral Risk Factor Surveillance System Survey Data; 2014. Available from: http://www.cdc.gov/brfss/data-documentation/index.htm.
9. Centers for Disease Control and Prevention. Behavioral Risk Factor Surveillance System Survey Data; 2015. Available from: http://www.cdc.gov/brfss/data-documentation/index.htm.
10. National Center for Health Statistics. National Health and Nutrition Examination Survey, 2013-2014. Public-use data file and documentation. Available from: http://wwwn.cdc.gov/nchs/nhanes/search/nhanes13-14.aspx.
11. Klein R, Proctor SE, Boudreault MA, Turczyn KM. Health People 2010 Criteria for Data Supression. Hyattsville, MD: Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Health Statistics; 2002. Available from: https://www.cdc.gov/nchs/data/statnt/statnt24.pdf.
12. Hu SS, Neff L, Agaku IT, Cox S, Day HR, Holder-Hayes E, et al. Tobacco product use among adults - United States, 2013-2014. MMWR Morb Mortal Wkly Rep 2016;65:685-91.
13. Singh T, Arrazola RA, Corey CG, Husten CG, Neff LJ, Homa DM, et al. Tobacco use among middle and high school students - United States, 2011-2015. MMWR Morb Mortal Wkly Rep 2016;65:361-7.
14. Kann L, McManus T, Harris WA, Shanklin SL, Flint KH, Hawkins J, et al. Youth Risk Behavior Surveillance - United States, 2015. MMWR Surveill Summ 2016;65:1-174.
15. Reagan-Steiner S, Yankey D, Jeyarajah J, Elam-Evans LD, Curtis CR, MacNeil J, et al. National, regional, state, and selected local area vaccination coverage among adolescents aged 13-17 years - United States, 2015. MMWR Morb Mortal Wkly Rep 2016;65:850-8.
16. US Department of Health andHuman Services. The Health Consequences of Smoking-50 Years of Progress. A Report from the Surgeon General. Atlanta, GA: Department of Health and Human Services. Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion; 2014. Available from: https://www.surgeongeneral.gov/library/reports/50-years-of-progress/.
17. Secretan B, Straif K, Baan R, Grosse Y, El Ghissassi F, Bouvard V, et al. A review of human carcinogens-Part E: tobacco, areca nut, alcohol, coal smoke, and salted fish. Lancet Oncol 200910:1033-4.
18. National Center for Health Statistics. Health, United States, 2015: With Special Feature on Racial and EthnicDisparities.Hyattsville, MD: National Center for Health Statistics; 2016.
19. Jamal A, King BA, Neff LJ, Whitmill J, Babb SD, Graffunder CM. Current cigarette smoking among adults - United States, 2005-2015. MMWR Morb Mortal Wkly Rep 2016;65:1205-11.
20. Dwyer-Lindgren L, Mokdad AH, Srebotnjak T, Flaxman AD, Hansen GM, Murray CJ. Cigarette smoking prevalence in US counties: 1996-2012. Popul Health Metr 2014;12:5.
21. Baker F, Ainsworth SR, Dye JT, Crammer C, Thun MJ, Hoffmann D, et al. Health risks associated with cigar smoking. JAMA 2000;284:735-40.
22. Shanks TG, Burns DM. Disease consequences of cigar smoking. National Cancer Institute, Smoking and Tobacco Control, Monograph 9: Cigars-Health Effects and Trends. Washington, DC: NIH; 1998.
23. Shapiro JA, Jacobs EJ, Thun MJ. Cigar smoking in men and risk of death from tobacco-related cancers. J Natl Cancer Inst 2000;92:333-7.
24. Campaign for Tobacco Free Kids. The rise of cigars and cigar-smoking harms; 2016. Available from: https://www.tobaccofreekids.org/research/factsheets/pdf/0333.pdf.
25. Wang TW, Kenemer B, Tynan MA, Singh T, King B. Consumption of combustible and smokeless tobacco - United States, 2000-2015.MMWR Morb Mortal Wkly Rep 2016;65:1357-63.
26. Cobb C, Ward KD, Maziak W, Shihadeh AL, Eissenberg T. Waterpipe tobacco smoking: an emerging health crisis in the United States. Am J Health Behav 2010;34:275-85.
27. Akl EA, Gaddam S, Gunukula SK, Honeine R, Jaoude PA, Irani J. The effects of waterpipe tobacco smoking on health outcomes: a systematic review. Int J Epidemiol 2010;39:834-57.
28. Raad D, Gaddam S, Schunemann HJ, Irani J, Abou Jaoude P, Honeine R, et al. Effects of water-pipe smoking on lung function: a systematic review and meta-analysis. Chest 2011;139:764-74.
29. El-Zaatari ZM, Chami HA, Zaatari GS. Health effects associated with waterpipe smoking. Tob Control 2015;24 Suppl 1:i31-i43.
30. Majeed BA, Sterling KL, Weaver SR, Pechacek TF, Eriksen MP. Prevalence and harm perceptions of hookah smoking among U.S. adults, 2014-2015. Addict Behav 2017;69:78-86.
31. Siddiqi K, Shah S, Abbas SM, Vidyasagaran A, Jawad M, Dogar O, et al. Global burden of disease due to smokeless tobacco consumption in adults: analysis of data from 113 countries. BMC Med 2015;13:194.
32. Boffetta P, Hecht S, Gray N, Gupta P, Straif K. Smokeless tobacco and cancer. Lancet Oncol 2008;9:667-75.
33. Malas M, van der Tempel J, Schwartz R, Minichiello A, Lightfoot C, Noormohamed A, et al. Electronic cigarettes for smoking cessation: a systematic review. Nicotine Tob Res 2016;18:1926-36.
34. Hartmann-Boyce J, McRobbie H, Bullen C, Begh R, Stead LF, Hajek P. Electronic cigarettes for smoking cessation. Cochrane Database Syst Rev 2016;9:CD010216.
35. Hajek P, Etter JF, Benowitz N, Eissenberg T, McRobbie H. Electronic cigarettes: review of use, content, safety, effects on smokers and potential for harm and benefit. Addiction 2014;109:1801-10.
36. Goniewicz ML, Knysak J, Gawron M, Kosmider L, Sobczak A, Kurek J, et al. Levels of selected carcinogens and toxicants in vapour from electronic cigarettes. Tob Control 2014;23:133-9.
37. King BA, Patel R, Nguyen KH, Dube SR. Trends in awareness and use of electronic cigarettes among US adults, 2010-2013. Nicotine Tob Res 2015;17:219-27.
38. Schoenborn CA, Gindi RM. Electronic cigarette use among adults: United States, 2014. NCHS Data Brief 2015;1-8. Available from: https://www.cdc.gov/nchs/products/databriefs/db217.htm
39. Centers for Disease Control and Prevention. Youth Tobacco Surveillance United States, 1998-1999. MMWR Surveill Summ 2000;49:1-104.
40. Monitoring the Future Survey, Institute for Social Research, University of Michigan. Table 7 CIGARETTES: Trends in 30-Day Prevalence of Use by Subgroups in Grade 12. Available from: http://monitoringthefuture.org/data/16data/16cigtbl7.pdf.
41. Centers for Disease Control and Prevention. Tobacco product use among middle and high school students-United States, 2011 and 2012. MMWR Morb Mortal Wkly Rep 2013;62:893-7.
42. Arrazola RA, Singh T, Corey CG, Husten CG, Neff LJ, Apelberg BJ, et al. Tobacco use among middle and high school students - United States, 2011-2014. MMWR Morb Mortal Wkly Rep 2015;64:381-5.
43. Miech R, Patrick ME, O'Malley PM, Johnston LD. What are kids vaping? Results from a national survey of US adolescents. Tob Control. 2016 Aug 25. [Epub ahead of print].
44. Singh T, Kennedy S, Marynak K, Persoskie A, Melstrom P, King BA. Characteristics of electronic cigarette use among middle and high school students - United States, 2015. MMWR Morb Mortal Wkly Rep 2016;65: 1425-9.
45. Doll R, Peto R, Boreham J, Sutherland I. Mortality in relation to smoking: 50 years' observation on male British doctors. BMJ 2004;328:1519-27.
46. Babb S, Malarcher A, Schauer G, Asman K, Jamal A. Quitting smoking among adults - United States, 2000-2015.MMWRMorb Mortal Wkly Rep 2017;65:1457-64.
47. Kohler LN, Garcia DO, Harris RB, Oren E, Roe DJ, Jacobs ET. Adherence to diet and physical activity cancer prevention guidelines and cancer outcomes: a systematic review. Cancer Epidemiol Biomarkers Prev 2016; 25:1018-28.
48. Lauby-Secretan B, Scoccianti C, Loomis D, Grosse Y, Bianchini F, Straif K. Body fatness and cancer-Viewpoint of the IARC Working Group. N Engl J Med 2016;375:794-8.
49. Fryar CD, Carroll MD, Ogden CL. Prevalence of overweight, obesity, and extreme obesity among adults: United States, 1960-1962 through 2011-2012; 2014. Hyattsville, MD: National Center for Health Statistics. Available from: http://www.cdc.gov/nchs/data/hestat/obesity-adult-11-12/obesity-adult-11-12.pdf.
50. Flegal KM, Kruszon-Moran D, Carroll MD, Fryar CD, Ogden CL. Trends in obesity among adults in the United States, 2005 to 2014. JAMA 2016; 315:2284-91.
51. National Center for Health Statistics. Health, United States, 2013: with a special feature on prescription drugs. Hyattsville, MD; 2014.
52. Ogden CL, Carroll MD, Lawman HG, Fryar CD, Kruszon-Moran D, Kit BK, et al. Trends in obesity prevalence among children and adolescents in the United States, 1988-1994 Through 2013-2014. JAMA 2016;315: 2292-9.
53. Kramer MR, Raskind IG, Van Dyke ME, Matthews SA, Cook-Smith JN. Geography of adolescent obesity in the U.S., 2007-2011. Am J Prev Med 2016;51:898-909.
54. Moore SC, Lee IM, Weiderpass E, Campbell PT, Sampson JN, Kitahara CM, et al. Association of leisure-time physical activity with risk of 26 types of cancer in 1.44 million adults. JAMA Intern Med 2016;176:816-25.
55. Centers for Disease Control and Prevention. QuickStats: percentage of adults aged 65 years meeting 2008 federal guidelines for leisure-time aerobic and muscle-strengthening activities, by age and type of activity -United States, 2000-2002 and 2013-2015. MMWR Morb Mortal Wkly Rep 2016;65:1019.
56. Kushi LH, Doyle C, McCulloughM, Gansler T, Courneya K, et al. American Cancer Society Guidelines on Nutrition and Physical Activity for cancer prevention: reducing the risk of cancer with healthy food choices and physical activity. CA Cancer J Clin 2012;62:30-67.
57. Marriott BP, Olsho L, Hadden L, Connor P. Intake of added sugars and selected nutrients in the United States, National Health and Nutrition Examination Survey (NHANES) 2003-2006. Crit Rev Food Sci Nutr 2010;50:228-58.
58. World Cancer Research Fund and American Institute for Cancer Research. Diet and Cancer Report. Washington, DC: Research Fund and American Institute for Cancer Research; 2007.
59. Jung S, Spiegelman D, Baglietto L, Bernstein L, Boggs DA, van den Brandt PA, et al. Fruit and vegetable intake and risk of breast cancer by hormone receptor status. J Natl Cancer Inst 2013;105:219-36.
60. Sinha R, Cross AJ, Graubard BI, Leitzmann MF, Schatzkin A. Meat intake and mortality: a prospective study of over half a million people. Arch Intern Med 2009;169:562-71.
61. Daniel CR, Cross AJ, Koebnick C, Sinha R. Trends in meat consumption in the USA. Public Health Nutr 2011;14:575-83.
62. Rehm CD, Penalvo JL, Afshin A, Mozaffarian D. Dietary intake among US adults, 1999-2012. JAMA 2016;315:2542-53.
63. Reedy J, Krebs-Smith SM, Miller PE, Liese AD, Kahle LL, Park Y, et al. Higher diet quality is associated with decreased risk of all-cause, cardiovascular disease, and cancer mortality among older adults. J Nutr 2014; 144:881-9.
64. US Department of Health and Human Services and US Department of Agriculture. Dietary Guidelines for Americans 2015-2020; 2015. Available from: https://health.gov/dietaryguidelines/2015/guidelines/.
65. World Cancer Research Fund and American Institute for Cancer Research. Food, Nutrition, Physical Activity and the Prevention of Cancer: A Global Perspective. Washington, DC: American Institute for Cancer Research; 2007.
66. International Agency for Research on Cancer. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Volume 83: Alcohol Drinking. Lyon, France: IARC Press; 1988.
67. Office of Disease Prevention and Health Promotion, Healthy People 2020. Objective SA-15 Reduce the proportion of adults who drank excessively in the previous 30 days. Available from: https://www.healthy people.gov/2020/data-search/Search-the-Data#objid=5207.
68. Karimkhani C, Boyers LN, Dellavalle RP, Weinstock MA. It's time for "keratinocyte carcinoma" to replace the term "nonmelanoma skin cancer". J Am Acad Dermatol 2015;72:186-7.
69. Rogers HW, Weinstock MA, Harris AR, Hinckley MR, Feldman SR, Fleischer AB, et al. Incidence estimate of nonmelanoma skin cancer in the United States, 2006. Arch Dermatol 2010;146:283-7.
70. GuyGP Jr, Thomas CC, Thompson T, Watson M, Massetti GM, Richardson LC. Vital signs: melanoma incidence and mortality trends and projections - United States, 1982-2030. MMWR Morb Mortal Wkly Rep 2015; 64:591-6.
71. International Agency for Research on Cancer. The association of use of sunbeds with cutaneous malignant melanoma and other skin cancers: a systematic review. Int J Cancer 2007;120:1116-22.
72. Boniol M, Autier P, Boyle P, Gandini S. Cutaneous melanoma attributable to sunbed use: systematic review and meta-analysis. BMJ 2012345:e4757.
73. Lazovich D, Vogel RI, Berwick M, Weinstock MA, Anderson KE, Warshaw EM. Indoor tanning and risk of melanoma: a case-control study in a highly exposed population. Cancer Epidemiol Biomarkers Prev 2010;19:1557-68.
74. Guy GP Jr, Berkowitz Z, HolmanDM, Hartman AM. Recent changes in the prevalence of and factors associated with frequency of indoor tanning among US adults. JAMA Dermatol 2015;151:1256-9.
75. Guy GP Jr, Berkowitz Z, Everett Jones S, Holman DM, Garnett E, Watson M. Trends in indoor tanning among US high school students, 2009-2013. JAMA Dermatol 2015;151:448-50.
76. Guy GP Jr, Berkowitz Z, Jones SE, Olsen EO, Miyamoto JN, Michael SL, et al. State indoor tanning laws and adolescent indoor tanning. Am J Public Health 2014;104:e69-74.
77. Plummer M, de Martel C, Vignat J, Ferlay J, Bray F, Franceschi S. Global burden of cancers attributable to infections in 2012: a synthetic analysis. Lancet Global Health 2016;4:e609-16.
78. Satterwhite CL, Torrone E, Meites E, Dunne EF, Mahajan R, Ocfemia MC, et al. Sexually transmitted infections among US women and men: prevalence and incidence estimates, 2008. Sex Transm Dis 2013;40: 187-93.
79. Saraiya M, Unger ER, Thompson TD, Lynch CF, Hernandez BY, Lyu CW, et al. US assessment of HPV types in cancers: implications for current and 9-valent HPV vaccines. J Natl Cancer Inst 2015;107:djv086.
80. Jemal A, Simard EP, Dorell C, Noone AM, Markowitz LE, Kohler B, et al. Annual Report to the Nation on the Status of Cancer, 1975-2009, featuring the burden and trends in human papillomavirus(HPV)-associated cancers and HPV vaccination coverage levels. J Natl Cancer Inst 2013;105:175-201.
81. Serrano B, de Sanjose S, Tous S, Quiros B, Munoz N, Bosch X, et al. Human papillomavirus genotype attribution for HPVs 6, 11, 16, 18, 31, 33, 45, 52 and 58 in female anogenital lesions. Eur J Cancer 2015;51: 1732-41.
82. American Academy of Pediatrics. ACIP updates recommendations on HPV, HepB, MenB vaccines. Available from: http://www.aappublications. org/news/2016/10/20/ACIP102016.
83. Saslow D, Andrews KS, Manassaram-Baptiste D, Loomer L, Lam KE, Fisher-Borne M, et al. Human papillomavirus vaccination guideline update: American Cancer Society guideline endorsement. CA Cancer J Clin 2016;66:375-85.
84. Smith RA, Andrews KS, Brooks D, Fedewa SA, Manassaram-Baptiste D, Saslow D, et al. Cancer screening in the United States, 2017: a review of current American Cancer Society Guidelines and current issues in cancer screening. CA Cancer J Clin 2017;67:100-21.
85. Williams WW, Lu PJ, O'Halloran A, Kim DK, Grohskopf LA, Pilishvili T, et al. Surveillance of vaccination coverage among adult populations -United States, 2014. MMWR Surveill Summ 2016;65:1-36.
86. Wroblewski LE, Peek RM Jr, Wilson KT. Helicobacter pylori and gastric cancer: factors that modulate disease risk. Clin Microbiol Rev 2010;23: 713-39.
87. Plummer M, Franceschi S, Vignat J, Forman D, de Martel C. Global burden of gastric cancer attributable to pylori. Int J Cancer 2015;136: 487-90.
88. Brown LM. Helicobacter pylori: epidemiology and routes of transmission. Epidemiol Rev 2000;22:283-97.
89. Grad YH, Lipsitch M, Aiello AE. Secular trends in Helicobacter pylori seroprevalence in adults in the United States: evidence for sustained race/ethnic disparities. Am J Epidemiol 2012;175:54-9.
90. Siao D, Somsouk M. Helicobacter pylori: evidence-based review with a focus on immigrant populations. J Gen Intern Med 2014;29:520-8.
91. International Agency for Research on Cancer. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans: Biological Agents. Lyon, France: International Agency for Cancer Research; 2012.
92. Engels EA, Cho ER, Jee SH. Hepatitis B virus infection and risk of non-Hodgkin lymphoma in South Korea: a cohort study. Lancet Oncol 2010;11:827-34.
93. Roberts H, Kruszon-Moran D, Ly KN, Hughes E, Iqbal K, Jiles RB, et al. Prevalence of chronic hepatitis B virus (HBV) infection in U.S. households: National Health and Nutrition Examination Survey (NHANES), 1988-2012. Hepatology 2016;63:388-97.
94. Kowdley KV, Wang CC, Welch S, Roberts H, Brosgart CL. Prevalence of chronic hepatitis B among foreign-born persons living in the United States by country of origin. Hepatology 2012;56:422-33.
95. Coppola N, Alessio L, Pisaturo M, Macera M, Sagnelli C, Zampino R, et al. Hepatitis B virus infection in immigrant populations. World J Hepatol 2015;7:2955-61.
96. Vijayadeva V, Spradling PR, Moorman AC, Rupp LB, Lu M, Gordon SC, et al. Hepatitis B virus infection testing and prevalence among Asian and Pacific Islanders. Am J Manag Care 2014;20:e98-e104.
97. Wasley A, Kruszon-Moran D, Kuhnert W, Simard EP, Finelli L, McQuillan G, et al. The prevalence of hepatitis B virus infection in the United States in the era of vaccination. J Infect Dis 2010;202:192-201.
98. Ioannou GN. Hepatitis B virus in the United States: infection, exposure, and immunity rates in a nationally representative survey. Ann Intern Med 2011;154:319-28.
99. de Sanjose S, Benavente Y, Vajdic CM, Engels EA, Morton LM, Bracci PM, et al. Hepatitis C and non-Hodgkin lymphoma among 4784 cases and 6269 controls from the International Lymphoma Epidemiology Consortium. Clin Gastroenterol Hepatol 2008;6:451-8.
100. Edlin BR, Eckhardt BJ, Shu MA, Holmberg SD, Swan T. Toward a more accurate estimate of the prevalence of hepatitis C in the United States. Hepatology 2015;62:1353-63.
101. Smith BD, Patel N, Beckett G, Ward JW. Hepatitis C virus antibody prevalence, correlates and predictors among persons born from 1945 through 1965, United States, 1999-2008 [abstract]; 2011. San Francisco, CA: American Association for the Study of Liver Diseases. Available from: https://liverlearning.aasld.org/aasld/2011/thelivermeeting/12758/.
102. Ly KN, Xing J, Klevens RM, Jiles RB, Ward JW, Holmberg SD. The increasing burden of mortality from viral hepatitis in the United States between 1999 and 2007. Ann Intern Med 2012;156:271-8.
103. Armstrong GL, Wasley A, Simard EP, McQuillan GM, Kuhnert WL, Alter MJ. The prevalence of hepatitis Cvirus infection in the United States, 1999 through 2002. Ann Intern Med 2006;144:705-14.
104. Denniston MM, Jiles RB, Drobeniuc J, Klevens RM, Ward JW, McQuillan GM, et al. Chronic hepatitis C virus infection in the United States, National Health and Nutrition Examination Survey 2003 to 2010. Ann Intern Med 2014;160:293-300.
105. Chak E, Talal AH, Sherman KE, Schiff ER, Saab S. Hepatitis C virus infection in USA: an estimate of true prevalence. Liver Int 2011;31: 1090-101.
106. Moyer VA, US Preventive Services Task Force. Screening for hepatitis C virus infection in adults: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 2013;159: 349-57.
107. Jemal A, Fedewa SA. Recent hepatitis C virus testing patterns among baby boomers. Am J Prev Med 2017;e1-e3. [Epub ahead of print]. DOI: 10.1016/j.amepre.2017.01.033.
108. Engels EA, Biggar RJ, Hall HI, Cross H, Crutchfield A, Finch JL, et al. Cancer risk in people infected with human immunodeficiency virus in the United States. Int J Cancer 2008;123:187-94.
109. Simard EP, Pfeiffer RM, Engels EA. Spectrum of cancer risk late after AIDS onset in the United States. Arch Intern Med 2010;170: 1337-45.
110. Shiels MS, Cole SR, Kirk GD, Poole C. A meta-analysis of the incidence of non-AIDS cancers in HIV-infected individuals. J Acquir Immune Defic Syndr 2009;52:611-22.
111. Silverberg MJ, Chao C, Leyden WA, Xu L, Tang B, Horberg MA, et al. HIV infection and the risk of cancers with and without a known infectious cause. AIDS 2009;23:2337-45.
112. Grulich AE, van Leeuwen MT, Falster MO, Vajdic CM. Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysis. Lancet 2007;370:59-67.
113. Engels EA. Non-AIDS-defining malignancies in HIV-infected persons: etiologic puzzles, epidemiologic perils, prevention opportunities. AIDS 2009;23:875-85.
114. Centers for Disease Control and Prevention. HIV Surveillance Report, 2015. Atlanta, GA: Center for Disease Control and Prevention; 2016. Available from: http://www.cdc.gov/hiv/library/reports/hiv-surveillance.html.
115. Centers for Disease Control and Prevention. Monitoring Selected National HIV Prevention and Care Objectives by Using HIV Surveillance Data-United States and 6 Dependent Areas-2013. Atlanta, GA: Centers for Disease Control and Prevention; 2015. Available from: https://www.cdc.gov/hiv/pdf/library/reports/surveillance/cdc-hiv-sur veillancereport-vol20-no2.pdf.
116. Hall HI, An Q, Tang T, Song R, Chen M, Green T, et al. Prevalence of diagnosed and undiagnosed HIV infection-United States, 2008-2012. MMWR Morb Mortal Wkly Rep 2015;64:657-62.
117. Rosenberg ES, Grey JA, Sanchez TH, Sullivan PS. Rates of prevalent HIV infection, prevalent diagnoses, and new diagnoses among men who have sex with men in US States, metropolitan statistical areas, and Counties, 2012-2013. JMIR Public Health Surveill 2016;2:e22.
118. Centers for Disease Control and Prevention. HIV and AIDS in the United States by geographic distribution. Available from: http://www.cdc.gov/hiv/statistics/overview/geographicdistribution.html.
119. Breen N, Gentleman JF, Schiller JS. Update on mammography trends: comparisons of rates in 2000, 2005, and 2008. Cancer 2011;117: 2209-18.
120. White A, Thompson TD, White MC, Sabatino SA, de Moor J, Doria-Rose PV, et al. Cancer screening test use - United States, 2015. MMWR Morb Mortal Wkly Rep 2017;66:201-6.
121. Schiffman MH, Castle PE, Jeronimo J, Rodriguez AC, Wacholder S. Human Papilloma Virus and cervical cancer. Lancet 2007;370: 890-907.
122. Edwards BK, Ward E, Kohler BA, Eheman C, Zuber AG, Anderson RN, et al. Annual report to the Nation on the Status of Cancer, 1975-2006, featuring colorectal trends and impact of interventions (Risk Factors, Screening, and Treatment) to reduce future rates. Cancer 2009;116: 544-73.
123. Klabunde CN, Cronin KA, Breen N, Waldron WR, Ambs AH, Nadel MR. Trends in colorectal cancer test use among vulnerable populations in the United States. Cancer Epidemiol Biomarkers Prev 2011;20: 1611-21.
124. Smith RA, Andrews K, Brooks D, DeSantis CE, Fedewa SA, Lortet-Tieulent J, et al. Cancer screening in the United States, 2016: A review of current American Cancer Society guidelines and current issues in cancer screening. CA Cancer J Clin 2016;66:95-114.
125. Wender R, Fontham ET, Barrera E Jr, Colditz GA, Church TR, Ettinger DS, et al. American Cancer Society lung cancer screening guidelines. CA Cancer J Clin 2013;63:107-17.
126. Moyer VA, US Preventive Services Task Force. Screening for lung cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 2014;160:330-8.
127. Jemal A, Fedewa SA. Lung cancer screening with low-dose computed tomography in the United States-2010 to 2015. JAMA Oncol 2017 Feb 2. [Epub ahead of print].
128. Etzioni R, Gulati R, Tsodikov A, Wever EM, Penson DF, Heijnsdijk EA, et al. The prostate cancer conundrum revisited: treatment changes and prostate cancer mortality declines. Cancer 2012;118:5955-63.
129. Schröder FH, Hugosson J, Roobol MJ, Tammela TL, Ciatto S, Nelen V, et al. Screening and prostate-cancer mortality in a randomized European study. N Engl J Med 2009;360:1320-8.
130. Andriole GL, Crawford ED, Grubb RL III, Buys SS, Chia D, Church TR, et al. Mortality results from a randomized prostate-cancer screening trial. N Engl J Med 2009;360:1310-9.
131. Wolf A, Wender RC, Etzioni RB, Thompson IM, D'Amico A, Volk RJ, et al. American Cancer Society Guideline for the early detection of prostate cancer: update 2010. CA Cancer J Clin 2010;60:70-98.
132. Draisma G, Etzioni R, Tsodikov A, Mariotto A, Wever E, Gulati R, et al. Lead time and overdiagnosis in prostate-specific antigen screening: importance of methods and context. J Natl Cancer Inst 2009;101: 374-83.
133. Wilt TJ, MacDonald R, Rutks I, Shamliyan TA, Taylor BC, Kane RL. Systematic review: comparative effectiveness and harms of treatments for clinically localized prostate cancer. Ann Intern Med 2008; 148:435-48.
134. U.S. Preventive Services Task Force. Draft Recommendation Statement Prostate Cancer Screening. Available from: https://www.uspreventiveservicestaskforce.org/Page/Document/RecommendationStatementDraft/prostate-cancer-screening1.
135. Jemal A, Fedewa SA, Ma J, Siegel R, Lin CC, Brawley O, et al. Prostate cancer incidence and PSA testing patterns in relation to USPSTF screening recommendations. JAMA 2015;314:2054-61.
136. Han PK, Kobrin S, Breen N, Joseph DA, Li J, Frosch DL, et al. National evidence on the use of shared decisionmaking in prostate-specific antigen screening. Ann Fam Med 2013;11:306-14.
137. Emmons KM, Colditz GA. Realizing the potential of cancer prevention -the role of implementation science. N Engl J Med 2017;376: 986-90.
138. Czajka JL, Beyler A. Background paper - declining response rates in federal surveys: trends and implications. Mathematica Policy Research; 2016;1:1-86. Available at: https://www.mathematica-mpr.com/our-publications-and-findings/publications/declining-responserates-in-federal-surveys-trends-and-implications-background-paper.
139. Center for Disease Control and Prevention.Methodologic changes in the Behavioral Risk Factor Surveillance System in 2011 and potential effects on prevalence estimates. MMWR Morb Mortal Wkly Rep 2012;61: 410-3.
140. DuBray P. Use of text messaging to increase response rates. Burlington, VT: ICF International; 2013.
141. de Leeuw ED. Data Quality in Mail, Telephone, and Face to Face Surveys. 1992. Available from: https://eric.ed.gov/?id=ED374136. ISBN: ISBN-90-801073-1-X.
142. Rauscher GH, Johnson TP, Cho YI, Walk JA. Accuracy of self-reported cancer-screening histories: ameta-analysis. Cancer Epidemiol Biomarkers Prev 2008;17:748-57.
143. Burgess DJ, Powell AA, Griffin JM, PartinMR. Race and the validity of selfreported cancer screening behaviors: development of a conceptual model. Prev Med 2009;48:99-107.